Chefer V I, Shippenberg T S
Integrative Neuroscience Unit, Behavioral Neuroscience Laboratory, NIH/NIDA Intramural Research Program, 5500 Nathan Shock Drive, Baltimore, MD 21224, USA.
Neuroscience. 2002;112(4):907-19. doi: 10.1016/s0306-4522(02)00099-4.
Despite an abundance of studies on mechanisms of behavioral sensitization, considerable uncertainty exists as to whether alterations in dopamine neurotransmission underlie the exacerbated behavioral effects of cocaine observed during the early stages of abstinence. One of the factors contributing to the uncertainty and controversy may be the limitations in utilized measurement techniques (mostly conventional microdialysis). The techniques of quantitative microdialysis under transient conditions and rotating disk electrode voltammetry were used to characterize basal dopamine dynamics as well as time-related changes in extracellular dopamine concentrations and dopamine uptake that occur in response to an acute drug challenge in control animals and animals with previous history of cocaine. Basal extracellular dopamine concentrations were unaltered on abstinence day 3 from repeated cocaine administration (5 days, 20 mg/kg, i.p.). The extraction fraction of dopamine, an indirect measure of dopamine uptake, was significantly lower in cocaine-sensitized animals relative to controls. These two facts, taken together, suggest that basal dopamine release is depressed in cocaine-sensitized animals on abstinence day 3. At the same time, a cocaine challenge decreased the extraction fraction and increased the extracellular dopamine concentration in both experimental groups. The magnitude of the increase in extracellular dopamine concentration was greater in cocaine-sensitized animals, while the ability of cocaine to decrease the extraction fraction was unaltered, suggesting that the increase in extracellular dopamine concentration reflects an increase in drug-evoked dopamine release. Moreover, cocaine-pretreated rats demonstrated greater depolarization-induced dopamine release and the ability of dopamine D(2) receptor agonist, quinpirole, to inhibit release was decreased in these animals. These data demonstrate that a cocaine treatment regimen resulting in behavioral sensitization is associated with a reduction in basal dopamine release, an enhancement in both cocaine and K(+)-evoked dopamine release, and a subsensitivity of dopamine D(2) autoreceptors that regulate dopamine release in the nucleus accumbens.
尽管对行为敏化机制进行了大量研究,但关于多巴胺神经传递的改变是否是禁欲早期观察到的可卡因行为效应加剧的基础,仍存在相当大的不确定性。导致这种不确定性和争议的因素之一可能是所使用测量技术(主要是传统微透析)的局限性。采用瞬态条件下的定量微透析技术和旋转圆盘电极伏安法来表征基础多巴胺动力学,以及在对照动物和有可卡因使用史的动物中,急性药物激发后细胞外多巴胺浓度和多巴胺摄取随时间的变化。重复给予可卡因(5天,20mg/kg,腹腔注射)后,禁欲第3天基础细胞外多巴胺浓度未改变。多巴胺摄取的间接指标——多巴胺提取率,在可卡因致敏动物中相对于对照显著降低。综合这两个事实表明,禁欲第3天可卡因致敏动物的基础多巴胺释放受到抑制。同时,给予可卡因激发后,两个实验组的多巴胺提取率均降低,细胞外多巴胺浓度均升高。可卡因致敏动物细胞外多巴胺浓度升高的幅度更大,而可卡因降低提取率的能力未改变,这表明细胞外多巴胺浓度的升高反映了药物诱发的多巴胺释放增加。此外,经可卡因预处理的大鼠表现出更大的去极化诱导的多巴胺释放,并且多巴胺D(2)受体激动剂喹吡罗抑制这些动物多巴胺释放的能力降低。这些数据表明,导致行为敏化的可卡因治疗方案与基础多巴胺释放减少、可卡因和K(+)诱发的多巴胺释放增强以及调节伏隔核中多巴胺释放的多巴胺D(2)自身受体的敏感性降低有关。